Biotechnology

Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal

Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next?

FDA Rejects ImmunityBio's Bladder Cancer Therapy Filing

Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next?

FDA Rejects ImmunityBio's Bladder Cancer Therapy Filing

Virios Therapeutics Up 75% On Fibromyalgia Phase 3 Proposal

After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade

Virios Therapeutics Up 75% On Fibromyalgia Phase 3 Proposal

After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade

Junior Biotech Stocks Outperforming In An Already Buoyant Market

Sponsored

Janney Upgrades bluebird bio Ahead Of Sickle Cell Presentation

Biotechnology Recent News

Equillium's IPO: What You Need To Know

Dicerna Pharma Has Multiple Pipeline Opportunities, Tough Competition, Analyst Says In Neutral Initiation

Turning Neutral: Morgan Stanley Downgrades Sarepta, Loxo Oncology, Global Blood Therapeutics

William Blair: Bluebird Bio Could See Another 'Blue Ribbon Year' In 2018

BofA: The Biotech Sector Is In A 'Perfect Storm' For M&A

It's A Bad Day For Biotechs

Analyst Sees 243% Upside For Corbus Pharma Following Positive Clinical Data

Endocyte Shares Up More Than 100% In 2 Days, But Analyst Sees Even More Upside Possible

3 Reasons To Like Vertex Pharma Shares

Pro: Biotech Is The Hottest ETF Of 2017 With Plenty Of Upside Ahead

Analyst Makes The Case For Ligand As A 'Core' Holding

3 Things Deutsche Bank Likes About Agilent's Q3, And One Thing To Be Cautious Of

Cramer: Small-Cap Biotechs Are Reserved For Speculative Investors

Cyclacel Pharmaceuticals' 35% Spike: Manipulation Or Something Else?

A Bull Call On A Marquee Healthcare ETF

6 Biotechs Still Awaiting December Catalysts

These Biotechs Are Getting Crushed Following Juno's Cancer Drug Hold

This Biotech ETF Could Be Ready To Party

Here's Why Prima BioMed Is Up 15%

4 Companies Pfizer Just Increased Its Stake In

Shares Of Chimerix Higher By Nearly 6% After Point72 Stake Reveal

Vetr Crowd No Longer Uber-Bearish On Puma Biotech

15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference